These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11955532)

  • 1. Severe pneumonia and a second antibiotic.
    Macfarlane J
    Lancet; 2002 Apr; 359(9313):1170-2. PubMed ID: 11955532
    [No Abstract]   [Full Text] [Related]  

  • 2. [Infection emergency: life threatening danger of Pneumococcus and co].
    Bischoff A
    MMW Fortschr Med; 2013 Oct; 155(18):18-20, 22. PubMed ID: 24288907
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimal antibiotic treatment in severe pneumococcal pneumonia--time for real answers.
    Waterer GW
    Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):691-2. PubMed ID: 16244854
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe community-acquired pneumococcal pneumonia -- what might be done better.
    Ewig S; Torres A
    Intensive Care Med; 1999 Feb; 25(2):143-5. PubMed ID: 10193539
    [No Abstract]   [Full Text] [Related]  

  • 5. Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia.
    Schaaf B; Kruse J; Rupp J; Reinert RR; Droemann D; Zabel P; Ewig S; Dalhoff K
    Eur Respir J; 2007 Sep; 30(3):517-24. PubMed ID: 17537775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia.
    Chokshi R; Restrepo MI; Weeratunge N; Frei CR; Anzueto A; Mortensen EM
    Eur J Clin Microbiol Infect Dis; 2007 Jul; 26(7):447-51. PubMed ID: 17534677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting combination antibiotic therapy for community-acquired invasive Streptococcus pneumoniae pneumonia.
    Mufson MA; Stanek RJ
    Clin Infect Dis; 2006 Jan; 42(2):304-6. PubMed ID: 16355349
    [No Abstract]   [Full Text] [Related]  

  • 8. [When does pneumonia belong in the hospital -- and when not. Community-acquired -- healed by ambulatory care?].
    MMW Fortschr Med; 2003 Mar; 145(10):12-3. PubMed ID: 12688019
    [No Abstract]   [Full Text] [Related]  

  • 9. Decrease in mortality in severe community-acquired pneumococcal pneumonia: impact of improving antibiotic strategies (2000-2013).
    Gattarello S; Borgatta B; Solé-Violán J; Vallés J; Vidaur L; Zaragoza R; Torres A; Rello J;
    Chest; 2014 Jul; 146(1):22-31. PubMed ID: 24371840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia.
    Naucler P; Darenberg J; Morfeldt E; Ortqvist A; Henriques Normark B
    Thorax; 2013 Jun; 68(6):571-9. PubMed ID: 23442364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Roles of the Charlson Comorbidity Index and Time to First Antibiotic Dose as Predictors of Outcome in Pneumococcal Community-Acquired Pneumonia.
    Franzen D; Lim M; Bratton DJ; Kuster SP; Kohler M
    Lung; 2016 Oct; 194(5):769-75. PubMed ID: 27405854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia.
    Spindler C; Ortqvist A
    Eur Respir J; 2006 Oct; 28(4):816-23. PubMed ID: 16737983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal therapy for severe pneumococcal community-acquired pneumonia.
    Luján M; Gallego M; Rello J
    Intensive Care Med; 2006 Jul; 32(7):971-80. PubMed ID: 16791660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of adult patients with community-acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association].
    Strålin K; Goscinski G; Hedlund J; Lidman C; Spindler C; Ortqvist A; Holmberg H
    Lakartidningen; 2008 Sep 17-23; 105(38):2582-7. PubMed ID: 18846863
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pulmonary infections].
    Rohde G
    Dtsch Med Wochenschr; 2011 Dec; 136(48):2486-8. PubMed ID: 22109582
    [No Abstract]   [Full Text] [Related]  

  • 16. Historical and regulatory perspectives on the treatment effect of antibacterial drugs for community-acquired pneumonia.
    Singer M; Nambiar S; Valappil T; Higgins K; Gitterman S
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S216-24. PubMed ID: 18986293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia].
    Roger PM; Risso K; Hyvernat H; Landraud L; Vassallo M; Dellamonica J; de Salvador F; Cua E; Bernardin G
    Med Mal Infect; 2010 Jun; 40(6):347-51. PubMed ID: 20172672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conundrums in community-acquired pneumonia.
    Bradley PJ
    Med J Aust; 2007 Jan; 186(2):102-3; author reply 103. PubMed ID: 17256185
    [No Abstract]   [Full Text] [Related]  

  • 19. Challenges in the Management of Pneumococcal Disease in Older Adults.
    Natarajan VS; Shankar BH
    J Assoc Physicians India; 2015 Apr; 63(4 Suppl):13-6. PubMed ID: 26562957
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of pneumococcal pneumonia: what's in an MIC?
    Crnich CJ; Proctor RA
    Crit Care Med; 2004 Mar; 32(3):876-8. PubMed ID: 15090976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.